Literature DB >> 29758

Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects.

A J Puech, P Simon, J R Boissier.   

Abstract

The effects of 6 benzamides and 8 classical neuroleptics were studied on 6 different apomorphine-induced effects. These drugs did not antagonize all the effects in the same way. The differences are discussed according to the two types of dopaminergic receptor hypothesis. Some apomorphine-induced effects (stereotyped behavior, circling behavior, climbing behavior, and increased motor activity) could be related to stimulation of one type of dopaminergic receptor, other effects (hypothermia and decreased activity) to the other type. Pimozide, sulpiride, thioproperazine, GRI 1665 and TER 1546, could block selectively one type of dopaminergic receptor, at least in a given range of doses. Clozapine, chlorpromazine, levomepromazine, and thioridazine, could block selectively the other type of dopaminergic receptor. Haloperidol, metoclopramide, prochlorperazine, sultopride, and tiapride, could block both types of dopaminergic receptors with equal intensity whatever the dose.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29758     DOI: 10.1016/0014-2999(78)90134-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

1.  In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia.

Authors:  J L Martinot; M L Paillère-Martinot; M F Poirier; M H Dao-Castellana; C Loc'h; B Mazière
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Rat climbing behavior elicited by stimulation of cerebral dopamine receptors.

Authors:  P Protais; J J Bonnet; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

3.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

4.  Effects of discriminant and non-discriminant dopamine antagonists on in vivo accumulation of 3H-N-propyl-norapomorphine in mouse striatum and tuberculum olfactorium.

Authors:  C Gulat-Marnay; A Lafitte; J C Schwartz; P Protais
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

5.  Dopamine receptors in canine caudate nucleus.

Authors:  H Maeno
Journal:  Mol Cell Biochem       Date:  1982-03-19       Impact factor: 3.396

6.  Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.

Authors:  S Usuda; K Nishikori; O Noshiro; H Maeno
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics.

Authors:  A J Puech; R Chermat; M Poncelet; L Doaré; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.

Authors:  T Alander; N E Andén; M Grabowska-Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

9.  Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites.

Authors:  M P Martres; P Sokoloff; M Delandre; J C Schwartz; P Protais; J Costentin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

10.  A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder.

Authors:  H M Standish-Barry; N Bouras; P K Bridges; J P Watson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.